Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.
about
Endothelial progenitor cells: what use for the cardiologist?Vascular Ageing and Exercise: Focus on Cellular Reparative ProcessesAge-related changes in brain support cells: Implications for stroke severityCardiovascular disease in lupus: insights and updatesIntracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicineWorking hypothesis to redefine endothelial progenitor cellsEndothelial progenitor cells: identity defined?Single- and double-walled carbon nanotubes enhance atherosclerogenesis by promoting monocyte adhesion to endothelial cells and endothelial progenitor cell dysfunctionPercutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cellsAssessment of endothelial dysfunction in childhood obesity and clinical use.Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal origin.Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells.Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery.GATA2 is associated with familial early-onset coronary artery disease.Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells.Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells.Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic controlBone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis.Effect of vitamin D on endothelial progenitor cells functionCerebral malaria: a vasculopathy.Endothelial progenitor cells: therapeutic perspective for ischemic stroke.Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular Disease.Ageing and endothelial progenitor cell release of proangiogenic cytokines.Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria.Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapyCirculating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk.Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetesGenous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment
P2860
Q21198698-22FD36F6-7FC5-4BFF-8A3A-863177C19FDCQ26772296-5EF63064-DC4E-473E-BEB7-73E5A869FAC0Q26860478-A1E93BCF-B658-4ED1-A337-0CA6E2BE55DCQ27016554-A5AD0612-82C4-4F4B-A11A-DC3577E43122Q27025843-8C98BEA9-635C-422F-9BE6-4B22C347CD8EQ27027618-E85921DA-BBA0-42A4-AD84-6C92410DBBEFQ28295515-59739747-E2C8-4C04-8BE1-909E46B0D535Q28303395-347B5109-F20B-4BF8-9FCB-27FE20DA5407Q28391649-3611E149-F831-4712-9D55-7EC2882D60B2Q28654918-6D24DA75-44F9-4553-B5D5-1432607C6CB2Q30430798-65DC779F-ADDA-4A82-B8B2-F50BE119CE14Q30495462-0EA096F2-8E9F-454C-91D2-95E68ACBA0B9Q30555841-AF6F59DE-BE47-4E98-B7B8-0A0227C63D96Q31028296-B66C4887-29B3-45A7-8C83-2D6285F7BC79Q32183787-EE933A0D-0311-4FE5-8DAF-607F72155D97Q33255348-42790071-E593-45F0-A53F-D66B8A041E52Q33267508-90659CC5-C86D-4FD6-8DE6-212343FD8BC6Q33410261-B4273EF8-21E8-4D5D-A1DE-80CC13755A3DQ33550596-D92CEC9B-ECB1-4736-90B2-2069A363237BQ33589465-F87C39A7-2F32-48B6-8C25-263D12F5E78EQ33632242-132D3FBC-8553-4858-8EC0-2E3AB530D5AAQ33633882-4DDB857D-8065-4045-826D-9C3556B9D1B9Q33699531-80F332E4-000B-4DAF-A80D-70DA9E4149D3Q33703604-C0D3BEF8-4DAB-4A5C-9619-ED86C0CCEC9CQ33705402-5CE1B9DC-D812-4358-8529-077727177B63Q33715270-D25C147B-2F8B-421A-A2B0-AF5CE7697EB0Q33722333-3317CE77-164C-40D5-9B6F-5D07CE8B5CC4Q33741062-2429D28C-2B02-45BD-9439-327873AADFE0Q33745065-8F418F3B-437B-4084-A86B-771932A0EC40Q33745962-8059A579-4601-401B-AAE5-5F97896259A5Q33751575-FF96E1F1-5E65-478C-B4CA-25BE4147009BQ33789760-CCAC1096-85F0-4AFE-9E9E-3DDE2FC12C60Q33793376-0231B7C2-DF40-42C6-80B4-01B5C7AF462BQ33796542-A131BE20-6CDC-43CD-9CE9-B4E7A0F9FA7BQ33804692-D8E6D382-DEE7-42F4-9353-A5A77A6668C5Q33820841-7665AC7A-588A-49BF-A58B-39359CA3E291Q33857901-7195AE6D-9A3D-4F99-80DE-BFCBA54C9A2FQ33888658-4277AC33-83B0-4EA3-BB00-B7A16333459BQ33927310-9C91FCC5-B25F-4B40-8D82-A16DCABE7732Q33943374-AF224AFB-B847-4E8A-B536-E605A9E903E9
P2860
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Reduced number of circulating ...... of endogenous vascular repair.
@en
type
label
Reduced number of circulating ...... of endogenous vascular repair.
@en
prefLabel
Reduced number of circulating ...... of endogenous vascular repair.
@en
P2093
P1433
P1476
Reduced number of circulating ...... of endogenous vascular repair.
@en
P2093
Caroline Schmidt-Lucke
Lothar Rössig
Mariuca Vasa
Martina Britten
Stephan Fichtlscherer
Ulrike Kämper
P304
P356
10.1161/CIRCULATIONAHA.104.504340
P407
P577
2005-05-31T00:00:00Z